JPX Equity Snapshot
4519 Weekly Equity Report
Chugai Pharmaceutical Co., Ltd.
What the company does
Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally. It offers oncology products, such as Alecensa, Avastin, FoundationOne, Herceptin, Kadcyla, Lunsumio, Perjeta, Phesgo, Polivy, and Tecentriq; Actemra for humanized anti-human IL-6 receptor monoclonal antibody; CellCept, an immunosuppressant; Enspryng, a pH-dependent binding humanized anti-IL-6 receptor monoclonal antibody; Evrysdi, a spinal muscular atrophy agent; Hemlibra, an anti-coagulation factor IXa/X humanized bispecific monoclonal antibody; Mircera, an erythropoiesis-stimulating agent; PiaSky, a pH-dependent binding humanized anti-complement (C5) monoclonal antibody; Tamiflu, an anti-influenza agent; and Vabysmo, …
What the weekly tape is saying
4519 closed the latest completed week at 7,450 JPY. The 4-week return is -6.1% and the 12-week return is -13.9%. Trend Signal is inactive, Market Dynamics is -1.13. Setup signature: Risk-first tape with a 23/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 8,531 JPY
- Vs Trend Line
- -12.7%
- Fair Value
- 6,392 JPY
- Vs Fair Value
- 16.6%
- 52W High
- 10,700 JPY
- 52W Low
- 5,838 JPY
- Drawdown
- -30.4%
- Range Position
- 33.2%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 27
- 52W Active Breadth
- 51.9%
- Sector Scope
- JP Healthcare
- Sector Rank
- 110 of 223
- Sector Percentile
- 50.9%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
JP Healthcare
- Tracked Peers
- 100
- 4W Rank
- 65 of 100
- Avg 1W
- -1.3%
- Avg 4W
- -3.4%
- Trend Breadth
- 27.0%
- Positive MD
- 28.0%
JP Drug Manufacturers - General
- Tracked Peers
- 8
- 4W Rank
- 3 of 8
- Avg 1W
- -1.7%
- Avg 4W
- -8.5%
- Trend Breadth
- 25.0%
- Positive RS
- 0.0%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- -1.13
- 4W MD Change
- -39.7%
- Relative Strength
- -26.88
- 4W RS Change
- -39.4%
- Expectation
- Positive
- Probability
- 63.20%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 12.7M
- 13W Average
- 13.5M
- 52W Average
- 13.2M
- Vs 13W
- 0.9x
- Vs 52W
- 1.0x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 3.7%
- 52W Volatility
- 5.1%
- Upside Weeks
- 29
- Downside Weeks
- 23
- Downside Breadth
- 44.2%
- Avg Gain / Loss
- 3.7% / -4.3%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- JPX
- Country
- JP
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Currency
- JPY
- Market Cap
- 12988.4B
Opportunity signals
- Price is above Fair Value, showing premium demand versus the model.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Market Dynamics is negative, which weakens the current setup.
- The share remains more than 20% below its 52-week high.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 7,450 JPY | -1.4% | 8,531 JPY | 6,392 JPY | -1.13 | -26.88 | 12.7M | Off |
| 5 Jun 2026 | 7,554 JPY | -4.3% | 8,549 JPY | 6,369 JPY | -1.10 | -27.19 | 12.6M | Off |
| 29 May 2026 | 7,892 JPY | -2.4% | 8,541 JPY | 6,345 JPY | -1.11 | -24.40 | 15.7M | Off |
| 22 May 2026 | 8,090 JPY | 1.9% | 8,509 JPY | 6,317 JPY | -1.02 | -19.57 | 10.5M | Off |
| 15 May 2026 | 7,938 JPY | 0.5% | 8,467 JPY | 6,288 JPY | -0.81 | -19.28 | 12.6M | Off |
| 8 May 2026 | 7,900 JPY | -4.2% | 8,427 JPY | 6,259 JPY | -0.81 | -21.93 | 11.0M | Off |
| 1 May 2026 | 8,245 JPY | -6.8% | 8,409 JPY | 6,229 JPY | -0.70 | -15.01 | 28.3M | On |
| 24 Apr 2026 | 8,845 JPY | 5.9% | 8,363 JPY | 6,198 JPY | -0.62 | -10.06 | 15.2M | On |
| 17 Apr 2026 | 8,349 JPY | -3.8% | 8,274 JPY | 6,162 JPY | -0.67 | -14.06 | 10.0M | On |
| 10 Apr 2026 | 8,675 JPY | -1.2% | 8,219 JPY | 6,129 JPY | -0.47 | -9.21 | 10.7M | On |
| 3 Apr 2026 | 8,779 JPY | 2.8% | 8,149 JPY | 6,093 JPY | -0.12 | -1.87 | 15.2M | On |
| 27 Mar 2026 | 8,540 JPY | -1.3% | 8,073 JPY | 6,056 JPY | 0.20 | -5.26 | 12.1M | On |
| 20 Mar 2026 | 8,650 JPY | -7.6% | 8,002 JPY | 6,021 JPY | 0.72 | -4.29 | 9.3M | On |
| 13 Mar 2026 | 9,362 JPY | -2.3% | 7,919 JPY | 5,985 JPY | 1.16 | 2.56 | 10.8M | On |